查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750829

ATP 檢測市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區、細分市場、預測（2025-2030 年）

ATP Assays Market Size, Share & Trends Analysis Report By Type (Luminometric ATP Assays, Enzymatic ATP Assays), By Application (Drug Discovery & Development, Clinical Diagnostics), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

ATP 檢測市場規模和趨勢

預計 2024 年全球 ATP 檢測市場規模為 35.6 億美元，2025 年至 2030 年複合年成長率為 7.91%。

這是由對快速靈敏的檢測方法的需求、製藥和生物技術研究中不斷擴大的應用、監管部門的核准以及慢性病負擔的增加所驅動的。

這些促進因素強調了 ATP檢測法在醫療保健、研究和工業領域的重要作用，促進了個人化醫療、藥物發現、環境監測、食品安全和品質檢測以及疾病控制方面的進步。根據 2022 年世界衛生組織的報告，食品污染影響全球約 6 億人，導致每年超過 200 種疾病，包括腹瀉等嚴重，造成 42 萬人死亡和 3,300 萬人失去健康年。

癌症、糖尿病、心血管疾病和感染疾病等慢性疾病的日益流行，推動了診斷檢測和疾病管理中對ATP檢測法的需求。根據世界衛生組織（WHO）2023年7月發布的報告，全球有1.16億人感染B肝，1,000萬人感染C肝，導致癌症、肝硬化和病毒性肝炎相關死亡。由於ATP水平可指示細胞功能障礙和疾病進展，這些測量值是疾病診斷、預後和療效監測的寶貴工具。隨著全球醫療保健系統面臨慢性疾病管理的挑戰，這些檢測有助於透過早期發現和個人化治療策略改善患者預後。

受污染的食品含有細菌、病毒、寄生蟲和化學物質等有害病原體，構成重大健康風險。 ATP 檢測試劑能夠快速且靈敏地檢測微生物的存在，在對抗食品污染方面至關重要。這些檢測試劑可測量三磷酸Adenosine，這是所有活細胞中普遍存在的微生物活性指標。 ATPAdenosine是評估食品表面、設備和加工區域清潔度的可靠指標。它們能夠快速識別污染源，使食品製造商、加工商和監管機構能夠立即採取糾正措施，並預防食源性疾病。在食品加工領域，這些產品能夠即時監測微生物，以監測衛生規範、檢驗清洗程序、確保符合安全標準，並在整個供應鏈中維護食品品質和安全。

技術創新在推動 ATP 檢測產業發展中發揮關鍵作用。檢測靈敏度、準確性和自動化程度的提高正在提高 AP 檢測方法的效能和可靠性。製造商正在開發整合生物發光、螢光和化學冷光等最尖端科技的新平台，以提供快速準確的測量。例如，Promega 的 RealTime-Glo 細胞外 ATP 檢測是一種生物發光方法，旨在檢測細胞在壓力、活化和凋亡過程中釋放的 ATP。它是評估誘導免疫原性細胞死亡的潛在治療方法的關鍵生物標記物，免疫抗原性細胞死亡是免疫反應調節的關鍵方面。這些進步正在滿足實驗室和診斷環境中對高效能篩檢和自動化工作流程日益成長的需求。

近年來，人們致力於提高檢測靈敏度、便利性和可負擔性，ATP 檢測產業因此迎來了顯著的產品創新和擴展。一個重要的例子是 BIoTium 於 2025 年 3 月推出的 Steady-ATP HTS 活力檢測試劑套件，這反映了該行業致力於支持製藥和生物技術研究中的高性能篩檢(HTS) 應用。新推出的檢測方法在 384 孔板中提供每孔 16 個細胞的超高靈敏度，並能產生半衰期超過 5 小時的穩定發光訊號。單步均質工作流程旨在簡化檢測通訊協定，並與自動化和 HTS 系統高度相容。重要的是，此檢測方法的性能可與 CellTiter-Glo 等高階市場替代品相媲美，但價格分佈卻更實惠。這項發展預計將鼓勵更廣泛地採用發光 ATP 檢測方法，尤其是在預算敏感的實驗室和新興生物技術公司中，從而支持整個 ATP 檢測行業的成長軌跡。此外，對方便用戶使用、經濟高效的檢測的關注與市場轉向在各種研究和品質測試領域實現即時、可擴展和高效的細胞活力和代謝研究相一致。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章 ATP 檢測市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業分析—波特五力分析
    • PESTEL分析
  • COVID-19對ATP檢測市場的影響
  • 區域級定價分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章 ATP 檢測市場類型、預測與趨勢分析

  • 細分儀表板
  • ATP 檢測市場：類型變異分析（2024 年 vs 2030 年）
    • 發光ATP測定法
    • 酶促ATP測定
    • 基於細胞的ATP測定
    • 其他
    • 抓鉗/夾子

第5章 ATP 檢測市場：按應用的估計和趨勢分析

  • 細分儀表板
  • ATP 檢測市場：2024 年和 2030 年應用趨勢分析
    • 藥物研發
    • 臨床診斷
    • 環境檢查
    • 食品安全和品質檢測
    • 其他

第6章 ATP 檢測市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • ATP 檢測市場：最終用途差異分析，2024 年 vs. 2030 年
    • 製藥和生物技術公司
    • 學術研究所
    • 醫院和診斷實驗室

第7章 ATP 檢測市場：區域、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業市場佔有率分析
    • Thermo Fisher Scientific
    • Promega Corporation
    • PerkinElmer Inc.
    • Becton, Dickinson and Company（BD）
    • Lonza Group Ltd.
    • Danaher Corporation
    • Abcam plc
    • Quest Diagnostics Incorporated
    • Biomerieux SA
    • 3M Company
Product Code: GVR-4-68040-390-2

ATP Assays Market Size & Trends:

The global ATP assays market size was estimated at USD 3.56 billion in 2024 and is projected to grow at a CAGR of 7.91% from 2025 to 2030. This is attributed to the demand for rapid and sensitive detection methods, expanding applications in pharmaceutical and biotechnology research, regulatory approvals, and the rising burden of chronic diseases.

These drivers underscore the critical role of ATP assays in healthcare, research, and industrial sectors, facilitating advancements in personalized medicine, drug discovery, environmental monitoring, food safety and quality testing, and disease management. The 2022 WHO report highlights that food contamination affects about 600 million people globally, leading to over 200 diseases annually, including severe conditions such as diarrhea, resulting in 420,000 deaths and 33 million healthy life years lost.

The increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and infectious diseases, drives the demand for ATP assays in diagnostic testing and disease management. According to the report published by World Health Organization (WHO) in July 2023, 116 million people live with hepatitis B and 10 million with hepatitis C, leading to cancer, liver cirrhosis, and viral hepatitis-related deaths, and around 3 million new infections occur annually, with most going undetected in the Western Pacific Region. ATP levels are indicative of cellular dysfunction and disease progression, making these assays valuable tools for disease diagnosis, prognosis, and monitoring therapeutic responses. As healthcare systems worldwide face the challenge of managing chronic conditions, assays contribute to improving patient outcomes through early detection and personalized treatment strategies.

Contaminated food contains harmful pathogens such as bacteria, viruses, parasites, and chemical substances, posing significant health risks. ATP assays are pivotal in combating food contamination by swiftly and sensitively detecting microbial presence. These assays measure adenosine triphosphate, a universal indicator of microbial activity found in all living cells. ATP levels serve as reliable markers for assessing cleanliness in food surfaces, equipment, and processing areas. They enable prompt identification of contamination sources, empowering food manufacturers, processors, and regulators to take immediate corrective actions to prevent foodborne illnesses. In food processing, these products monitor hygiene practices, validate cleaning procedures, ensure compliance with safety standards, and enable real-time microbial monitoring to uphold food quality and safety across supply chains.

Technological innovations play a pivotal role in driving the ATP assays industry forward. Advances in assay sensitivity, accuracy, and automation have enhanced the performance and reliability of AP detection methods. Manufacturers are developing novel platforms that integrate cutting-edge technologies such as bioluminescence, fluorescence, and chemiluminescence to provide rapid and precise measurements. For instance, The RealTime-Glo Extracellular ATP Assay by Promega Corporation is a bioluminescent method designed to detect ATP released from cells undergoing stress, activation, or apoptosis. It serves as a pivotal biomarker for assessing treatments that may induce immunogenic cell death, a significant aspect of immune response modulation. These advancements cater to the growing demand for high-throughput screening and automated workflows in research laboratories and diagnostic settings.

The ATP assays industry is witnessing notable product innovation and expansion, with recent developments aimed at enhancing assay sensitivity, convenience, and affordability. A key example is Biotium's launch of the Steady-ATP HTS Viability Assay Kit in March 2025, which reflects the industry's focus on supporting high-throughput screening (HTS) applications in pharmaceutical and biotech research. The newly launched assay offers ultra-high sensitivity, detecting as few as 16 cells per well in a 384-well format, and delivers a stable luminescent signal with an extended half-life of over 5 hours. Its single-step, homogeneous workflow is designed to simplify assay protocols, making it highly compatible with automation and HTS systems. Importantly, the assay delivers performance comparable to premium market alternatives, such as CellTiter-Glo, while being positioned at a more accessible price point. This development is expected to drive broader adoption of luminescent ATP assays, particularly in budget-sensitive research laboratories and emerging biotech companies, supporting the overall growth trajectory of the ATP assays industry. Furthermore, the focus on user-friendly and cost-effective assays aligns with the market's shift toward enabling real-time, scalable, and high-efficiency cell viability and metabolic studies across various research and quality testing domains.

Global ATP Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global ATP assays market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Luminometric ATP Assays
  • Enzymatic ATP Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
  • Cell-based ATP Assays
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Discovery & Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety & Quality Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospital & Diagnostics Laboratories
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Norway
    • Sweden
    • Denmark
    • Spain
    • Italy
    • France
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. ATP Assays Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID 19 on ATP Assays market
  • 3.4. Pricing Analysis, at Regional Level
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. MEA

Chapter 4. ATP Assays Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. ATP Assays Market: Type Movement Analysis, 2024 & 2030 (USD Million)
    • 4.2.1. Luminometric ATP Assays
      • 4.2.1.1. Luminometric ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Enzymatic ATP Assays
      • 4.2.2.1. Enzymatic ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Cell-based ATP Assays
      • 4.2.3.1. Cell-based ATP Assays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Graspers/ Clips

Chapter 5. ATP Assays Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. ATP Assays Market: Application Movement Analysis, 2024 & 2030 (USD Million)
    • 5.2.1. Drug Discovery and Development
      • 5.2.1.1. Drug Discovery and Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Clinical Diagnostics
      • 5.2.2.1. Clinical Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Environmental Testing
      • 5.2.3.1. Environmental Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Food Safety and Quality Testing
      • 5.2.4.1. Food Safety and Quality Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ATP Assays Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. ATP Assays Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
    • 6.2.1. Pharmaceutical and Biotechnology Companies
      • 6.2.1.1. Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Academic and Research Institutes
      • 6.2.2.1. Academic and Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Hospital and Diagnostics Laboratories
      • 6.2.3.1. Hospital and Diagnostics Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ATP Assays Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2024
    • 8.3.2. Thermo Fisher Scientific
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Promega Corporation
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. PerkinElmer Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Becton, Dickinson and Company (BD)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Lonza Group Ltd.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Danaher Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Abcam plc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Quest Diagnostics Incorporated
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Biomerieux SA
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. 3M Company
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global ATP Assays Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Mexico ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Europe ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Europe ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 UK ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Germany ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 France ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Italy ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Italy ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Italy ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Spain ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Spain ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Spain ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Denmark ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Sweden ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Sweden ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Sweden ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Norway ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Norway ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Norway ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 53 Japan ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Japan ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Japan ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 China ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 China ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 China ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 India ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 South Korea ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Australia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Thailand ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 Latin America ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Brazil ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa ATP Assays Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE ATP Assays Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ATP Assays Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ATP Assays Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait ATP Assays Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ATP Assays market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 ATP Assays market: Type movement analysis
  • Fig. 17 ATP Assays market: Type segment dashboard
  • Fig. 18 ATP Assays market Type outlook: Key takeaways
  • Fig. 19 Luminometric ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymatic ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bioluminescence Resonance Energy Transfer (BRET) ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Cell-based ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 ATP Assays market: Application movement analysis
  • Fig. 25 ATP Assays market Application outlook: Key takeaways
  • Fig. 26 Drug Discovery and Development ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical Diagnostics ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Environmental Testing ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Food Safety and Quality TestingATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 ATP Assays market: End use movement analysis
  • Fig. 32 ATP Assays market End use outlook: Key takeaways
  • Fig. 33 Pharmaceutical and Biotechnology Companies ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Academic and Research Institutes ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Hospital and Diagnostics Laboratories ATP Assays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Regional outlook, 2024 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 44 UK ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 45 Germany ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 47 France ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 54 China ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 55 India ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait ATP Assays Market, 2018 - 2030 (USD Million)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators